Keywords: abbott, files, snda, kaletra, tablets, submitted, supplemental

Abbott files sNDA for Kaletra tablets

Article | 09 May 2005

Print This

Abbott has submitted a supplemental New Drug Application to the US Food and Drug Administration seeking clearance to market a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in